해조류 추출물을 포함하는 식품 조성물 및 그의 용도
    1.
    发明公开
    해조류 추출물을 포함하는 식품 조성물 및 그의 용도 无效
    包含阿拉伯提取物的食品组合物及其用途

    公开(公告)号:KR1020130054518A

    公开(公告)日:2013-05-27

    申请号:KR1020110119926

    申请日:2011-11-17

    Abstract: PURPOSE: A usage for health promoting food, a whitening cosmetic product, and a medicine using a seaweed methanol extract are provided to offer various biological activities including an antioxidant effect, a whitening effect, and an anti-inflammatory effect. CONSTITUTION: Porphyra yezoensis, Undaria pinnatifida, Hizikia fusiformis, Capsosiphon fulvescens, Enteromorpha Linza are collected. The seaweeds are washed and dried, then soaked in 500ml of 70% methanol for 100g of seaweeds before extracting for a week. The extract is filtered by using filtering paper. The filtered material is freeze-dried after the concentration by using an evaporator. [Reference numerals] (AA) Hizikia fusiformis; (BB) Porphyra yezoensis; (CC) Undaria pinnatifida; (DD) Enteromorpha Linza; (EE) Capsosiphon fulvescens

    Abstract translation: 目的:提供健康促进食品,美白化妆品和使用海草甲醇提取物的药物的用途,以提供各种生物活性,包括抗氧化作用,美白效果和抗炎作用。 构成:收集紫菜,紫花苜蓿,烟丝,辣椒,枸杞子。 将海藻洗涤并干燥,然后在500ml 70%甲醇中浸泡100g海藻,然后提取一周。 萃取液用滤纸过滤。 通过使用蒸发器将过滤的物质在浓缩后冷冻干燥。 (AA)Hizikia fusiformis; (BB)紫菜紫菜; (CC)Undaria pinnatifida; (DD)Enteromorpha Linza; (EE)Capsosiphon fulvescens

    나르제니신을 포함하는 염증성 신경퇴행성 질환의 치료용 제약 조성물
    2.
    发明公开
    나르제니신을 포함하는 염증성 신경퇴행성 질환의 치료용 제약 조성물 失效
    用于治疗包含神经氨酸的炎症性神经病变性疾病的药物组合物

    公开(公告)号:KR1020100071835A

    公开(公告)日:2010-06-29

    申请号:KR1020080130684

    申请日:2008-12-19

    CPC classification number: A61K39/05 C07D493/10 Y10S514/886

    Abstract: PURPOSE: A pharmaceutical composition containing nargenicin for treating inflammatory agent and inflammatory neurodegenerative disease is provided to weaken iNOS mRNAexpression and NO generation. CONSTITUTION: A pharmaceutical composition for inflammatory neurodegenerative disease comprises nargenicin as an active ingredient and pharmaceutically acceptable carrier. A pharmaceutical composition for anti-inflammatory comprises nargenicin as an active ingredient and pharmaceutically acceptable carrier. The nargenicin is an antibiotic isolated from the Actinomyces Nocardia sp. CS682. Composition is made of pharmaceutical preparation of refinement, capsule, soft capsule agent, liquor, ointments or injection.

    Abstract translation: 目的:提供含有用于治疗炎症因子和炎症性神经退行性疾病的Nargenicin的药物组合物,用于削弱iNOS mRNA表达和NO产生。 构成:用于炎症性神经变性疾病的药物组合物包含作为活性成分的大球蛋白和药学上可接受的载体。 用于抗炎的药物组合物包含作为活性成分的大球蛋白和药学上可接受的载体。 Nargenicin是从诺卡氏菌属分离得到的抗生素。 CS682。 组合物由精制药剂,胶囊剂,软胶囊剂,药液,软膏或注射剂制成。

    나르제니신을 포함하는 염증성 신경퇴행성 질환의 치료용 제약 조성물
    3.
    发明授权
    나르제니신을 포함하는 염증성 신경퇴행성 질환의 치료용 제약 조성물 失效
    用于治疗炎症性神经退行性疾病的药物组合物,其包括纳菌素

    公开(公告)号:KR101022564B1

    公开(公告)日:2011-03-16

    申请号:KR1020080130684

    申请日:2008-12-19

    Abstract: 본 발명은 나르제니신을 유효 성분으로 포함하는 것을 특징으로 하는 항염증제 및 염증성 신경 퇴행성 질환용 제약 조성물에 관한 것이다. 본 발명의 조성물은 BV-2 세포에 있어서 LPS-유발 유도성 질소 산화물 합성(iNOS) mRNA 발현 및 NO 생산을 완전히 약화시킬 수 있으므로 효율적인 항염증제 및 신경퇴행성 질환의 치료제로 효과적으로 사용될 수 있다.
    나르제니신, 신경퇴행성 질환.

    버섯형질전환을 이용한 재조합단백질 생산 방법 및 그의 산물
    4.
    发明公开
    버섯형질전환을 이용한 재조합단백질 생산 방법 및 그의 산물 无效
    使用麦克风转化生产重组蛋白的方法及其产物

    公开(公告)号:KR1020100116072A

    公开(公告)日:2010-10-29

    申请号:KR1020090034803

    申请日:2009-04-21

    CPC classification number: C12N15/63 C07K14/475 C12N1/14 C12Q1/686

    Abstract: PURPOSE: A method for preparing a recombinant protein by mushroom transformation is provided to obtain useful material and to utilize as a novel microorganism production system. CONSTITUTION: A method for preparing a functional protein from mushrooms comprises: a step of constructing an expression vector which produces the functional protein; a step of transforming the expression vector to mushrooms by Agrobacterium vacuum infiltration or particle bombardment; a step of isolating genomic DNA and performing PCR or a step of performing southern blot and northern blot for confirming transformant expression; a step of isolating the functional protein from the transformant.

    Abstract translation: 目的:提供通过蘑菇转化制备重组蛋白的方法,以获得有用的材料并用作新型微生物生产系统。 构成:从蘑菇制备功能性蛋白质的方法包括:构建产生功能性蛋白质的表达载体的步骤; 通过农杆菌真菌浸润或粒子轰击将表达载体转化为蘑菇的步骤; 分离基因组DNA并进行PCR的步骤或进行Southern印迹和Northern印迹以确认转化体表达的步骤; 从功能性蛋白质与转化体分离的步骤。

    발아 쥐눈이콩을 이용한 과자류 재료의 제조 방법
    5.
    发明公开
    발아 쥐눈이콩을 이용한 과자류 재료의 제조 방법 无效
    用终止的红霉素制备功能性SNACK材料的方法

    公开(公告)号:KR1020090129562A

    公开(公告)日:2009-12-17

    申请号:KR1020080055539

    申请日:2008-06-13

    CPC classification number: A23L7/152 A23G3/48 A23L3/44 A23L11/05 A23L27/22

    Abstract: PURPOSE: A method for preparing the functional snack material by using the germinated Rhynchosia volubilis is provided to produce the snack very suitable for baby and infant by using no chemical additive or synthetic coloring. CONSTITUTION: A method for preparing the functional snack material comprises the steps of adding water to Rhynchosia volubilis, adding glutamic acid of 100 ~ 300 ppm or adding chitosan (M.W. 5000) 0.03 ~0.06% to dip it for 5 ~ 8 hours, and germinating it at about 25°C to the length of 5 ~ 20 mm; freeze-drying the germinated Rhynchosia volubilis and grinding it finely; and optionally adding about 4 ~ 7 times amount of water to the germinated Rhynchosia volubilis powder, extracting it 2~3 times at a room temperature or at 95 ~ 100°C, concentrating it under reduced pressure, and freeze-drying it.

    Abstract translation: 目的:提供通过使用发芽的Rhynchosia volubilis制备功能性快餐材料的方法,以通过不使用化学添加剂或合成着色来生产非常适合婴儿和婴儿的小吃。 构成:制备功能性快餐材料的方法包括以下步骤:向Rhynchosia volubilis加入水,加入100〜300ppm的谷氨酸或加入壳聚糖(MW 5000)0.03〜0.06%,浸泡5〜8小时,发芽 它在约25°C至5〜20mm的长度; 冷冻干燥发芽的Rhynchosia volubilis并精细研磨; 并向发芽的Rhynchosia volubilis粉末中加入约4〜7倍量的水,在室温或95〜100℃下提取2〜3次,减压浓缩,冷冻干燥。

Patent Agency Ranking